PCSK9 Inhibitors: The Need for a Patient-Centered Approach to Hyperlipidemia Management
January 7th 2022
This activity highlights an overview of hyperlipidemia and updated guideline recommendations for healthcare professionals as they are intricately involved in identifying appropriate candidates for PCSK9 inhibitor therapy, educating patients, monitoring clinical responses, and working with clinicians to implement crucial interventions.